StockMinded Weekly Recap – AI Volatility, Macro Crosswinds & Hims & Hers Rebound

Hello StockMinded readers,

This week in markets was shaped by a mix of macro uncertainty, AI-sector positioning, and healthcare headlines. While major indices moved mostly sideways, underneath the surface there was significant dispersion across sectors.

Here is the clean breakdown of the most important developments across equities and macro markets this week.

Macro sentiment stayed cautious this week as investors continued to balance two opposing forces:

• resilient economic data
• uncertainty around the path of interest rates

Bond yields moved within a tight range while equity volatility remained elevated compared to the start of the year. Investors are increasingly sensitive to macro surprises because the market narrative is still centered around one key question:

How quickly can central banks ease policy without reigniting inflation?

This dynamic has kept positioning relatively cautious, especially in high-multiple technology stocks.

At the same time, commodities like gold have remained supported as investors hedge against macro uncertainty and geopolitical risks.

The AI trade remains intact, but the tone has shifted from pure momentum to selective positioning.

Instead of everything AI-related rallying at once, markets are now differentiating between:

• companies monetizing AI infrastructure
• companies simply spending on AI
• speculative AI-adjacent names driven by sentiment

Large infrastructure players and semiconductor leaders continue to anchor the theme, but volatility in smaller AI names has increased significantly.

This is typical for a market phase where investors move from early hype to execution-driven evaluation.

One of the most notable individual stock stories this week involved Hims & Hers Health, which saw renewed investor attention after legal tensions involving Novo Nordisk.

Earlier pressure on Hims & Hers shares was tied to legal concerns around compounded GLP-1 weight-loss drugs. However, the stock rebounded this week as investors reassessed the long-term impact.

Key points investors focused on:

• demand for GLP-1 treatments remains extremely strong
• telehealth distribution channels are expanding rapidly
• regulatory outcomes remain uncertain but manageable in the near term

The rebound shows that markets still see meaningful growth potential in digital healthcare platforms even as regulatory scrutiny increases.

You can read the full article here.

A message from our sponsor:

In our new white paper, The Architecture Behind AI-Native Revenue Automation, Tabs CTO Deepak Bapat breaks down what it actually takes to apply AI to revenue workflows without breaking the books.

You’ll learn why probabilistic reasoning isn’t enough for finance, how Tabs pairs LLMs with deterministic logic, and why a unified Commercial Graph is the foundation for scalable, audit-ready automation. From contract interpretation to cash application, this paper goes deep on where AI belongs—and where it absolutely doesn’t.

If you’re evaluating AI for billing, collections, or revenue operations, this is the architecture perspective most vendors won’t show you.

Get the whitepaper

Even though major indices did not move dramatically this week, several important market signals emerged:

• increased sector dispersion
• higher volatility in speculative growth names
• stronger flows into defensive sectors

This type of market behavior usually appears when investors are transitioning between narratives.

Right now, the market is balancing three competing forces:

Several catalysts could shape market direction in the coming days:

• new inflation and labor market data
• earnings updates from technology and financial companies
• regulatory developments in healthcare and AI
• commodity price movements tied to geopolitical risk

Markets remain highly headline-driven, meaning sudden news flow can still trigger sharp short-term moves.

This week reinforced a key theme for 2026 markets: selectivity matters more than ever.

AI remains the dominant structural growth story, but investors are increasingly demanding proof of monetization and disciplined spending.

At the same time, macro uncertainty continues to limit broad market momentum, keeping volatility elevated beneath the surface.

For now, the market isn’t abandoning growth — it’s simply becoming more selective about where that growth is coming from.

Best regards,
Team StockMinded